Another experimental study indicated that the coexpression of mutant forms of β-catenin and YAP1 leads to the activation of YAP and Wnt signalling, which subsequently contributes to the development of hepatoblastoma, providing potential targets for future HB treatment (Min et al., 2019). This evidence concerns the gene YAP1 and hepatoblastoma.